| Q37530893 | A comparative study of CIDP in a cohort of HIV-infected and HIV-uninfected patients |
| Q82029761 | AIDS dementia complex |
| Q33750280 | AIDS dementia complex |
| Q36476913 | AIDS dementia complex and HIV-1 infection: a view from the clinic |
| Q50759629 | Assessment of HIV-intrathecal humoral immune response in AIDS-related neurological disorders. |
| Q86646236 | Bacterial infections of the central nervous system |
| Q37073672 | Biomarkers of HIV related central nervous system disease |
| Q40458885 | Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis. |
| Q40455681 | Blood-CSF barrier and compartmentalization of CNS cellular immune response in HIV infection. |
| Q37407370 | Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV. |
| Q34792090 | Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected Subjects |
| Q35654754 | Cerebrospinal fluid (CSF) analyses in HIV-1 primary neurological disease |
| Q34537999 | Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection |
| Q24814874 | Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment |
| Q33237758 | Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study |
| Q33732728 | Cerebrospinal fluid HIV-1 p24 antigen and culture: sensitivity and specificity for AIDS-dementia complex |
| Q45759166 | Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group |
| Q82029827 | Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex |
| Q39334682 | Clinical features of tuberculosis among adults in sub-Saharan Africa in the 21st century |
| Q44258650 | Cognitive behavior in asymptomatic (CDC stage II and III) HIV--seropositive intravenous drug users (IVDUs). |
| Q38551796 | Compartmentalized intrathecal immunoglobulin synthesis during HIV infection - a model of chronic CNS inflammation? |
| Q28341520 | Declining incidence of AIDS dementia complex after introduction of zidovudine treatment |
| Q37689076 | Delayed diagnosis of human immunodeficiency virus infection in a patient with non-specific neurological symptoms and pancytopenia: a case report |
| Q48899585 | Effects of antiretroviral treatment on blood-brain barrier integrity and intrathecal immunoglobulin production in neuroasymptomatic HIV-1-infected patients |
| Q40699313 | Evaluation and treatment of HIV-related illnesses in the emergency department |
| Q35951650 | Factors affecting delivery of antiviral drugs to the brain |
| Q37980665 | Genotypical diversity of HIV clades and central nervous system impairment |
| Q40540897 | Global challenges in human immunodeficiency virus and syphilis coinfection among men who have sex with men. |
| Q34563942 | HIV and the central nervous system. |
| Q37178574 | HIV-related neuropathy: current perspectives |
| Q45145239 | Human choroid plexus cells can be latently infected with human immunodeficiency virus |
| Q30886381 | Human immunodeficiency virus glycoprotein 160 induces cytokine mRNA expression in the rat central nervous system |
| Q36640545 | Human immunodeficiency virus type 1 infection of the brain |
| Q53974855 | Immune complex deposition in the choroid plexus of patients with acquired immunodeficiency syndrome. |
| Q43796945 | Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals--correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels |
| Q33283465 | Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy |
| Q44307034 | Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease. |
| Q55019131 | Ischemic Stroke in an HIV Positive Patient: An Initial Presentation of Neurosyphilis. |
| Q36750975 | Laboratory evaluations in HIV-1-associated cognitive/motor complex. |
| Q45783330 | Long-latency event-related potentials in asymptomatic human immunodeficiency virus type 1 infection |
| Q48329715 | Longitudinal study of EEG and evoked potentials in neurologically asymptomatic HIV infected subjects |
| Q37089861 | NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS. |
| Q56989910 | Neurological and neuropshychological manifestations of HIV-1 infection: Association with AIDS-related complex but not asymptomatic HIV-1 infection |
| Q36334043 | Neurosurgical aspects of human immunodeficiency virus infection. |
| Q56656831 | Neurosyphilis |
| Q43420582 | Neurosyphilis in patients infected with human immunodeficiency virus |
| Q36166516 | Neurosyphilis: A Current Review |
| Q33257724 | Normalisation of cerebrospinal fluid biomarkers parallels improvement of neurological symptoms following HAART in HIV dementia--case report |
| Q45397193 | Otoneurological findings in human immunodeficiency virus positive patients |
| Q30613846 | PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section |
| Q69367944 | Peripheral facial nerve palsy associated with HIV infection |
| Q38247035 | Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system |
| Q70755536 | Predictive value of neurological abnormalities in HIV 1 patients in the early stages of the infection |
| Q42208551 | Prevalence and predictors of blood-brain barrier damage in the HAART era. |
| Q82029803 | Progressive multifocal leukoencephalopathy |
| Q41529059 | Quantification of cerebrospinal fluid lactic acid in the differential diagnosis between HIV chronic meningitis and opportunistic meningitis |
| Q45864984 | Radiological study of the brain at various stages of human immunodeficiency virus infection: early development of brain atrophy |
| Q38633801 | Recent advances in the neurology of HIV infection |
| Q45759163 | Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain |
| Q45844090 | Syphilitic uveitis in human immunodeficiency virus-infected and noninfected patients |
| Q45423920 | Syphilitic uveitis in patients infected with human immunodeficiency virus |
| Q40468179 | The Use of Methylphenidate for Cognitive Decline Associated with HIV Disease |
| Q37849349 | The changing face of neurosyphilis |
| Q33934512 | The pathogenesis of the neurological complications of HIV-1 infection. |
| Q59353094 | Transient and asymptomatic meningitis in human immunodeficiency virus-1 subtype C: a case study of genetic compartmentalization and biomarker dynamics |
| Q37091975 | Vestibular function in HIV patients: preliminary report |
| Q45401097 | Viral load determines the B-cell response in the cerebrospinal fluid during human immunodeficiency virus infection |
| Q50506570 | [Effect of antiretroviral treatment on early electroencephalographic and otoneurologic manifestations in HIV infection and prognostic importance of verified perturbations] |